4.3453.77% ( -0.170 )
Delay Closed: Nov 16, 16:08:11Valuation
Current ValuationThe current P/E ratio is -32.03, above the reasonable range, cheaper than 17.62% of the time in the past 1 years, and the industry ranks 13/15, the industry Median 12.44.
-32.03xP/E
HK$4.35Stock price
HK$-0.14Earnings per share
-32.03xP/E
Stock priceHK$4.35Earnings per shareHK$-0.14
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- -37.61x
- Typical range
- -59.97x–-32.72x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 12.44x
013263952
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 12.44x
0x10x20x30x40x50x
| Name/Symbol | |||
|---|---|---|---|
01548HKGENSCRIPT BIO | -13.94x | 102.62% | HK$69.62B |
03347HKTIGERMED | -64.01x | -- | HK$30.17B |
02228HKXTALPI | -97.74x | 167.69% | HK$23.74B |
03696HKINSILICO | -8.95x | 100.56% | HK$20.88B |
02576HKTAIMEI TECH | -32.03x | -- | HK$2.40B |
08225HKC HEALTH GP | -5.43x | -- | HK$88.59M |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
